Teva Pharmaceutical Industries Ltd
BMV:TEVAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Teva Pharmaceutical Industries Ltd
BMV:TEVAN
|
IL |
|
R
|
Renault SA
XMUN:RNL
|
FR |
|
V
|
Vistra Corp
F:0V6
|
US |
|
UniCredit SpA
F:CRIN
|
IT |
|
F
|
Fairfax Financial Holdings Ltd
F:FFX
|
CA |
|
BOK Financial Corp
F:BJR
|
US |
|
Banco Santander SA
F:BSDK
|
ES |
Wall St Price Targets
TEVAN Price Targets Summary
Teva Pharmaceutical Industries Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TEVAN's stock price target?
Not Available
TEVAN does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 3 years is 2%.
What is the Gross Profit forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -1%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 11%.
What is the Pre-Tax Income forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
56%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 56%.
What is the Net Income forecast for Teva Pharmaceutical Industries Ltd?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 3 years is 44%.
